| Mutations associated with acquired resistance to PD-1 blockade in melanoma JM Zaretsky, A Garcia-Diaz, DS Shin, H Escuin-Ordinas, W Hugo, ... New England Journal of Medicine 375 (9), 819-829, 2016 | 3162 | 2016 |
| Interferon receptor signaling pathways regulating PD-L1 and PD-L2 expression A Garcia-Diaz, DS Shin, BH Moreno, J Saco, H Escuin-Ordinas, ... Cell reports 19 (6), 1189-1201, 2017 | 1806 | 2017 |
| Primary Resistance to PD-1 Blockade Mediated by JAK1/2 Mutations DS Shin, JM Zaretsky, H Escuin-Ordinas, A Garcia-Diaz, S Hu-Lieskovan, ... Cancer discovery 7 (2), 188-201, 2017 | 1239 | 2017 |
| Cerebrospinal fluid-derived circulating tumour DNA better represents the genomic alterations of brain tumours than plasma L De Mattos-Arruda, R Mayor, CKY Ng, B Weigelt, F Martínez-Ricarte, ... Nature communications 6 (1), 8839, 2015 | 798 | 2015 |
| Neutrophil to lymphocyte ratio (NLR) as an indicator of poor prognosis in stage IV non-small cell lung cancer S Cedres, D Torrejon, A Martinez, P Martinez, A Navarro, E Zamora, ... Clinical and Translational Oncology 14, 864-869, 2012 | 363 | 2012 |
| Conserved interferon-γ signaling drives clinical response to immune checkpoint blockade therapy in melanoma CS Grasso, J Tsoi, M Onyshchenko, G Abril-Rodriguez, ... Cancer cell 38 (4), 500-515. e3, 2020 | 323 | 2020 |
| Serum tumor markers CEA, CYFRA21-1, and CA-125 are associated with worse prognosis in advanced non–small-cell lung cancer (NSCLC) S Cedrés, I Nuñez, M Longo, P Martinez, E Checa, D Torrejón, E Felip Clinical lung cancer 12 (3), 172-179, 2011 | 313 | 2011 |
| Primary resistance to PD-1 blockade mediated by JAK1/2 mutations. Cancer Discov. 2017; 7: 188–201. doi: 10.1158/2159-8290 DS Shin, JM Zaretsky, H Escuin-Ordinas, A Garcia-Diaz, S Hu-Lieskovan, ... CD-16-1223.[Europe PMC free article][Abstract][CrossRef][Google Scholar], 0 | 249 | |
| PAK4 inhibition improves PD-1 blockade immunotherapy G Abril-Rodriguez, DY Torrejon, W Liu, JM Zaretsky, TS Nowicki, J Tsoi, ... Nature Cancer 1 (1), 46-58, 2020 | 128 | 2020 |
| Overcoming genetically based resistance mechanisms to PD-1 blockade DY Torrejon, G Abril-Rodriguez, AS Champhekar, J Tsoi, KM Campbell, ... Cancer discovery 10 (8), 1140-1157, 2020 | 126 | 2020 |
| Uncoupling interferon signaling and antigen presentation to overcome immunotherapy resistance due to JAK1 loss in melanoma A Kalbasi, M Tariveranmoshabad, K Hakimi, S Kremer, KM Campbell, ... Science translational medicine 12 (565), eabb0152, 2020 | 108 | 2020 |
| Exploratory analysis of activation of PTEN–PI3K pathway and downstream proteins in malignant pleural mesothelioma (MPM) S Cedres, MA Montero, P Martinez, A Martinez, V Rodriguez-Freixinos, ... Lung cancer 77 (1), 192-198, 2012 | 76 | 2012 |
| Melanoma dedifferentiation induced by IFN-γ epigenetic remodeling in response to anti–PD-1 therapy YJ Kim, KM Sheu, J Tsoi, G Abril-Rodriguez, E Medina, CS Grasso, ... The Journal of clinical investigation 131 (12), 2021 | 51 | 2021 |
| Relación entre toxocariosis y asma:: estudio prospectivo en niños del Hospital Nacional Cayetano Heredia, Lima, Perú L Gétaz Schaller, F Samalvides Cuba, J Breña Chavez, D Torrejon, ... Acta Médica Peruana 24 (2), 11-20, 2007 | 35 | 2007 |
| SEGUNDA PARTE C Maguiña-Vargas, F Osores, H Farías, D Torrejón, T Alcorta Dermatología Peruana 15 (1), 38-50, 2005 | 33 | 2005 |
| Primary resistance to PD-1 blockade mediated by JAK1/2 mutations. Cancer Discov. 7, 188–201 DS Shin, JM Zaretsky, H Escuin-Ordinas, A Garcia-Diaz, S Hu-Lieskovan, ... | 29 | 2017 |
| Implication of breast cancer phenotype for patients with leptomeningeal carcinomatosis D Torrejón, M Oliveira, J Cortes, G Sanchez-Olle, P Gómez, M Bellet, ... The Breast 22 (1), 19-23, 2013 | 28 | 2013 |
| Expression of Wilms’ tumor gene (WT1) is associated with survival in malignant pleural mesothelioma S Cedrés, MA Montero, E Zamora, A Martínez, P Martínez, L Fariñas, ... Clinical and Translational Oncology 16, 776-782, 2014 | 27 | 2014 |
| Cerebrospinal fluid-derived circulating tumour DNA better represents the genomic alterations of brain tumours than plasma. Nat Commun 6: 8839 L De Mattos-Arruda, R Mayor, CK Ng, B Weigelt, F Martínez-Ricarte, ... Epub 2015/11/12, 2015 | 22 | 2015 |
| Primary resistance to PD-1 blockade mediated by JAK1/2 mutations. Cancer Discov. 2017; 7: 188–201 DS Shin, JM Zaretsky, H Escuin-Ordinas, A Garcia-Diaz, S Hu-Lieskovan, ... | 16 | |
